| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| April 29, 2026 | ±3.7% | -1.2% | over-priced |
| October 30, 2025 | ±2.4% | +0.6% | over-priced |
| July 31, 2025 | ±2.3% | -0.2% | over-priced |
| May 1, 2025 | ±4.2% | -0.5% | over-priced |
| October 30, 2024 | ±1.9% | -1.7% | over-priced |
| July 31, 2024 | ±3.1% | +1.7% | over-priced |
| May 2, 2024 | ±3.4% | +0.1% | over-priced |
| November 2, 2023 | ±2.2% | +1.5% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q1 FY2026 | $1.15 | $6.8B | $605M |
| Q4 FY2025 | $1.06 | $6.8B | $557M |
| Q3 FY2025 | $1.12 | $6.7B | $590M |
| Q2 FY2025 | $1.37 | $7.5B | $724M |
Paccar Inc (PCAR) reports in 91 days, with the next report estimated for September 12, 2026. Across the last 8 reports, options priced an average ±2.9% earnings move while the stock actually moved 0.9% on average — the market has systematically over-priced PCAR's earnings risk. Fundamentals into the print: EPS up 19.8% year-over-year, revenue down 8.9%. QuantLogix's live 5-factor engine currently reads PCAR as a buy at 56/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →